<!DOCTYPE html>
<meta charset="utf8" />
<html>
<link
  rel="stylesheet"
  href="https://cdn.jsdelivr.net/npm/@picocss/pico@2/css/pico.classless.min.css"
/>
<body>
    <header>
        <nav>
            <ul>
                <li><h1>QuiVoteQuoi?</h1></li>
            </ul>
            <ul>
                <li><a href="/subjects">Sujets</a></li>
            </ul>
        </nav>
    </header>
    <main>
        <section>
            <a href="/">⟵ Retourner à la recherche</a>
            <h2>Resolution on Commission Implementing Regulation (EU) 2021/52 of 22 January 2021 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin</h2>
            <h3>Sujets</h3>
            <ul>
                
                    
                    <li><a href="/subject/3.10.09">Phytosanitaire, phytopharmacie, agriculture biologique, agro-génétique: généralités</a></li>
                
            </ul>
            <h3>Votes</h3>
            
            <ul>
                
                <li><a href="/vote/128852">Objection formulée conformément à l'article 112, paragraphes 2 et 3: substances actives, notamment la dimoxystrobine - Objection pursuant to Rule 112(2) and (3): Active substances, including dimoxystrobin - Einwand gemäß Artikel 112 Absätze 2 und 3 (GO): Wirkstoffe wie Dimoxystrobin - B9-0162/2021 - Proposition de résolution</a></li>
                
            </ul>
        </section>
    </main>
</body>
</html>